Rodin Therapeutics (United States)
- Research works
- 25 ▲ 51% vs 2013–17
- Citations
- 428 17.3 per fractional work
- Top-10% rate
- 15.0% record average 16.5%
- Open access
- 42% world 28%
Not ranked overall: Rodin Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 11.4×. Every wedge is a field page.
Which keywords describe research at Rodin Therapeutics (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer, Inflammation, Neurodegeneration, Cancer Therapy, Oxidative Stress, Parkinson's Disease, Apoptosis and Immune Response.
- Angiogenesis
- Neuroinflammation
- Virulence Factors
- Apoptosis
- Cancer Therapy
- Epidemiology
- Cancer
- Inflammation
- Oxidative Stress
- Neurodegeneration
- Parkinson's Disease
- Immune Response
- Drug Discovery
- Transcriptional Regulation
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 14 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 14 words, with their numbers
- Inflammation3▲ 4.8×15 topics
- Cancer3▲ 7.5×15 topics
- Oxidative Stress2▲ 4.6×9 topics
- Epidemiology2▲ 2.0×14 topics
- Neurodegeneration2▲ 25×6 topics
- Cancer Therapy2▲ 12×7 topics
- Parkinson's Disease2▲ 26×5 topics
- Apoptosis1▲ 14×7 topics
- Immune Response1▲ 8.9×6 topics
- Virulence Factors1▲ 25×3 topics
- Drug Discovery1▲ 11×4 topics
- Neuroinflammation1▲ 17×3 topics
- Transcriptional Regulation1▲ 18×4 topics
- Angiogenesis1▲ 10×4 topics
Which research topics does Rodin Therapeutics (United States) publish most on?
By volume in 2022–2025: Toxoplasma gondii Research Studies, Synthesis and biological activity, Advanced Radiotherapy Techniques and Melanoma and MAPK Pathways.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Toxoplasma gondii Research Studies Parasitology 0 works
- 2 Synthesis and biological activity Organic Chemistry 0 works
- 3 Advanced Radiotherapy Techniques Radiation 0 works
- 4 Melanoma and MAPK Pathways Molecular Biology 0 works
- 5 Cancer Mechanisms and Therapy Pathology and Forensic Medicine 0 works
- 6 Herpesvirus Infections and Treatments Epidemiology 0 works
- 7 Cytomegalovirus and herpesvirus research Epidemiology 0 works
- 8 Management of metastatic bone disease Surgery 0 works
- 9 Cancer Treatment and Pharmacology Oncology 0 works
- 10 Genomics and Rare Diseases Genetics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Rodin Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 51% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cambridge
- Harvard University
- Massachusetts Institute of Technology
- Center for Astrophysics Harvard & Smithsonian
- National Bureau of Economic Research
- IIT@MIT
- World Wide Web Consortium
- Broad Institute
- Smithsonian Astrophysical Observatory
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.